Samarth Kulkarni, CEO: Crispr Therapeutics CRSP Sell · Filed 25/10/20

Trade details

Type: Insider sale
Amount: $3,456,279.45
Shares · price: 50,895 sh · $67.91 a share
Held after: 254,201 sh
Stock: Crispr Therapeutics CRSP
Person: Samarth KulkarniCEO
Trade date: 25/10/17
Filed: 25/10/20
Days to filing: 3 days

Sold 16.7% of holdings

Share of holding sold: 16.7%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/17~25/11/16

Samarth Kulkarni's recent trades

Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$468.7K
10,020 sh
$468.7K
Filed 03/24
Traded 03/23
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$499.4K
10,349 sh
$499.4K
Filed 03/17
Traded 03/16
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$517.3K
9,798 sh
$517.3K
Filed 03/12
Traded 03/11
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$366.3K
6,967 sh
$366.3K
Filed 02/20
Traded 02/19
Samarth KulkarniCEO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$3.6M
60,000 sh
$3.6M
Filed 01/22
Traded 01/22